glp-1 antagonists receptor agonists show promise in treating substance use disorders Dual and Triple Gut Peptide

Dardano A, Bianchi C, Garofolo M, Del Prato S

For Dr Ambrish Mithal, chairman of endocrinology and diabetes at Max Healthcare, the study answers a long-standing question about the effects of discontinuing GLP-1 drugs during pregnancy

16 Hims & Hers Health, a U.S.-based telemedicine company, has recently announced future plans to provide GLP-1RA drugs as part of its new weight-loss platform, alongside personalized nutrition guidance, digital tracking tools, mental health support, etc

Countries like China and India are experiencing a surge in demand for diabetes management solutions, supported by government initiatives aimed at improving healthcare infrastructure

The influence of SGLT2 inhibitors, dipeptidyl peptidase IV (DPP-4) inhibitors, and sulfonylureas on cancer risk remains inconclusive